SCHEMBL1084577

SCHEMBL1084577

O=C(C1CCCO1)N1CCN(c2nc(-c3ccccc3O)nc3cc(Cl)ccc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 1/20 0.48
KDM4E B2RXH2 7/20 0.46
HTT P42858 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 4/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 8/20 0.45
TSHR P16473 3/20 0.45
MAPT P10636 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HSD17B10 Q99714 4/20 0.45
LMNA P02545 4/20 0.44
GAA P10253 2/20 0.44
ALOX12 P18054 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
HPGD P15428 4/20 0.44
CASP1 P29466 1/20 0.44
MAPK1 P28482 2/20 0.43
GLA P06280 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12721564 0.90 KDM4E (0.54) SMAD3KDM4EHTTSMN1; SMN2POLB
SCHEMBL1084414 0.90 KDM4E (0.54) SMAD3KDM4EHTTSMN1; SMN2POLB
SCHEMBL1084205 0.84 SMAD3 (0.48) SMAD3KDM4EHTTSMN1; SMN2KMT2A
SCHEMBL1084360 0.83 SMAD3 (0.54) SMAD3KMT2AMEN1ALDH1A1TSHR
SCHEMBL1084374 0.82 SMAD3 (0.53) SMAD3KMT2AMEN1ALDH1A1TSHR
SCHEMBL1084249 0.81 MEN1 (0.56) SMAD3KMT2AMEN1ALDH1A1TSHR
SCHEMBL1084204 0.79 PIK3CA (0.59) SMAD3KDM4EHTTSMN1; SMN2KMT2A
SCHEMBL1084381 0.77 SMAD3 (0.54) SMAD3KMT2AMEN1ALDH1A1TSHR
SCHEMBL1084422 0.77 MEN1 (0.74) SMAD3KDM4EKMT2AMEN1ALDH1A1
SCHEMBL1084465 0.77 SMAD3 (0.58) SMAD3KDM4EKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed